[1] RUNHAAR J, ZHANG Y. Can we prevent OA? Epidemiology and public health insights and implications. RHEUMATOLOGY. 2018;57(4):3-9.
[2] CROSS M, SMITH E, HOY D, et al. The global burden of hip and knee osteoarthritis: estimates from the Global Burden of Disease 2010 study. Ann Rheum Dis. 2014;73(7):1323-1330.
[3] WOOLF AD, PFLEGER B. Burden of major musculoskeletal conditions. Bull World Health Organ.2003;81(9):646-656.
[4] MCALINDON TE, BANNURU RR, SULLIVAN MC, et al. OARSI guidelines for the non-surgical management of knee osteoarthritis. Osteoarthritis Cartilage. 2014;22(3):363-388.
[5] ESTADES-RUBIO FJ, REYES-MARTÍN A, MORALES-MARCOS V, et al. Knee Viscosupplementation:Cost-Effectiveness Analysis between Stabilized Hyaluronic Acid in a Single Injection versus Five Injections of Standard Hyaluronic Acid.Int J Mol Sci. 2017;18(3).
[6] MONTAÑEZ-HEREDIA E, IRÍZAR S, HUERTAS P, et al. Intra-Articular Injections of Platelet-Rich Plasma versus Hyaluronic Acid in the Treatment of Osteoarthritic Knee Pain: A Randomized Clinical Trial in the Context of the Spanish National Health Care System. Int J Mol Sci. 2016;17(7). pii: E1064.
[7] YIN J, XU Z, LIU J. Alleviation of synovitis caused by joint instability with application of platelet-rich plasma. Thromb Res. 2019;186: 20-25.
[8] R O. Implantación de condrocitos autólogos versus microfracturas para el tratamiento de lesiones del cartílago en la rodilla. Acta Ortopédica Mexicana.2018;32(6):322-328.
[9] HOLT K, SORHAINDO M, COADY C, et al. Arthroscopic Treatment of Medial Femoral Knee Osteochondral Defect Using Subchondroplasty and Chitosan-Based Scaffold. Arthrosc Tech. 2019;8(4):e413-e418.
[10] HANGODY L, KISH G, KARPATI Z, et al. Mosaicplasty for the treatment of articular cartilage defects: application in clinical practice. ORTHOPEDICS.1998;21(7):751-756.
[11] SATO M, YAMATO M, MITANI G, et al. Combined surgery and chondrocyte cell-sheet transplantation improves clinical and structural outcomes in knee osteoarthritis. NPJ Regen Med. 2019;4:4.
[12] HINCKEL BB, GOMOLL AH. Autologous Chondrocytes and Next-Generation Matrix-Based Autologous Chondrocyte Implantation. Clin Sports Med. 2017;36(3):525-548.
[13] KAUR A, BHOOP BS, CHHIBBER S, et al. Kaur A BBCS. Supramolecular nano-engineered lipidic carriers based on diflunisal- phospholipid complex for transdermal delivery: QbD based optimization, characterization and preclinical investigations for management of rheumatoid arthritis. Int J Pharm. 2017;533(1):206-224.
[14] LAMPLOT JD, SCHAFER KA, MATAVA MJ. Treatment of Failed Articular Cartilage Reconstructive Procedures of the Knee: A Systematic Review. Orthop J Sports Med. 2018;6(3): 2325967118761871.
[15] GRACITELLI GC, MORAES VY, FRANCIOZI CE, et al. Surgical interventions (microfracture, drilling, mosaicplasty and allograft transplantation) for treating isolated cartilage defects of the knee in adults.Cochrane Database Syst Rev. 2016;9:CD010675.
[16] VERONESI F, GIAVARESI G, TSCHON M, et al. Clinical Use of Bone Marrow, Bone Marrow Concentrate, and Expanded Bone Marrow Mesenchymal Stem Cells in Cartilage Disease.Stem Cells Dev. 2013; 22(2):181-192.
[17] FRISCH J,ORTH P,VENKATESAN JK,et al.Genetic Modification of Human Peripheral Blood Aspirates Using Recombinant Adeno- Associated Viral Vectors for Articular Cartilage Repair With a Focus on Chondrogenic Transforming Growth Factor-β Gene Delivery. Stem Cells Transl Med. 2017;6(1):249-260.
[18] LI K, HU Y. Cartilage Tissue Engineering: Recent Advances and Perspectives from Gene Regulation/Therapy. Advanced Healthcare Materials. 2015;4(7):948-968.
[19] CHERIAN JJ, PARVIZI J, BRAMLET D, et al. Preliminary results of a phase II randomized study to determine the efficacy and safety of genetically engineered allogeneic human chondrocytes expressing TGF-β1 in patients with grade 3 chronic degenerative joint disease of the knee. Osteoarthritis Cartilage. 2015;23(12):2109-2118.
[20] MIKKO S, MONONEN ME, SALO J, et al. Quantitative Evaluation of the Mechanical Risks Caused by Focal Cartilage Defects in the Knee. Scientific Reports.2016; 6(1):37538.
[21] GOMOLL AH, MINAS T. The quality of healing: Articular cartilage. Wound Repair Regen. 2014;22 Suppl 1:30-138.
[22] GIELIS WP, WELSING PMJ, VAN SPIL WE, et al. A sex-specific association between incident radiographic osteoarthritis of hip or knee and incident peripheral arterial calcifications: 8-year prospective data from Cohort Hip and Cohort Knee (CHECK). Osteoarthritis Cartilage. 2017;25(11):1814-1821.
[23] MAPP PI, WALSH DA. Mechanisms and targets of angiogenesis and nerve growth in osteoarthritis. Nat Rev Rheumatol. 2012;8(7):390-398.
[24] GROL MW, LEE BH.Gene therapy for repair and regeneration of bone and cartilage. Curr Opin Pharmacol. 2018,40:59-66.
[25] JONAS S, IZAURRALDE E. Towards a molecular understanding of microRNA-mediated gene silencing.Nat Rev Genet. 2015;16(7):421- 433.
[26] BAO C, CHEN H, MOU X, et al. GZMB gene silencing confers protection against synovial tissue hyperplasia and articular cartilage tissue injury in rheumatoid arthritis through the MAPK signaling pathway.Biomed Pharmacother. 2018;103:346-354.
[27] BANDARA G, MUELLER GM, GALEA-LAURI J, et al. Intraarticular expression of biologically active interleukin 1-receptor-antagonist protein by ex vivo gene transfer. Proc Natl Acad Sci U S A.1993;90(22): 10764-10768.
[28] CHE JH, ZHANG ZR, LI GZ, et al. Application of tissue-engineered cartilage with BMP-7 gene to repair knee joint cartilage injury in rabbits. Knee Surg Sports Traumatol Arthrosc. 2010;18(4):496-503.
[29] HEINZERLING L, BURG G, DUMMER R, et al. Intratumoral injection of DNA encoding human interleukin 12 into patients with metastatic melanoma: clinical efficacy. Hum Gene Ther. 2005;16(1):35-48.
[30] YANG Z, ZHANG H, DUAN C, et al. IGF1 regulates RUNX1 expression via IRS1/2: Implications for antler chondrocyte differentiation. Cell Cycle. 2017;16(6):522-532.
[31] WU S, FADOJU D, REZVANI G, et al. Stimulatory Effects of Insulin-like Growth Factor-I on Growth Plate Chondrogenesis Are Mediated by Nuclear Factor-κB p65.J Biol Chem. 2008;283(49):34037-34044.
[32] MUNGER KL, CHITNIS T, FRAZIER AL, et al. Dietary intake of vitamin D during adolescence and risk of multiple sclerosis. J Neurol. 2011; 258(3):479-485.
[33] TRIANT VA. HIV Infection and Coronary Heart Disease: An Intersection of Epidemics. J Infect Dis. 2012;205 Suppl 3:S355-S361.
[34] MARIANI E, PULSATELLI L, FACCHINI A. Signaling Pathways in Cartilage Repair. Int J Mol Sci. 2014;15(5):8667-8698.
[35] ZHANG Z, LI L, YANG W, et al. The effects of different doses of IGF-1 on cartilage and subchondral bone during the repair of full-thickness articular cartilage defects in rabbits.Osteoarthritis Cartilage. 2017; 25(2): 309-320.
[36] LIU P, SUN L, CHEN H, et al. Lentiviral-mediated multiple gene transfer to chondrocytes promotes chondrocyte differentiation and bone formation in rabbit bone marrow-derived mesenchymal stem cells.Oncol Rep. 2015;34(5):2618-2626.
[37] ASHRAF S, CHA BH, KIM JS, et al. Regulation of senescence associated signaling mechanisms in chondrocytes for cartilage tissue regeneration. Osteoarthritis Cartilage.2016;24(2):196-205.
[38] YING J, WANG P, ZHANG S, et al. Transforming growth factor-beta1 promotes articular cartilage repair through canonical Smad and Hippo pathways in bone mesenchymal stem cells. Life Sci. 2018;192:84-90.
[39] KATAGIRI T, WATABE T. Bone Morphogenetic Proteins.Cold Spring Harb Perspect Biol. 2016;8(6). pii: a021899.
[40] WU M, CHEN G, LI Y. TGF-β and BMP signaling in osteoblast, skeletal development, and bone formation, homeostasis and disease. Bone Res. 2016;4:16009.
[41] NISHIMURA R, HATA K, MATSUBARA T, et al. Regulation of bone and cartilage development by network between BMP signalling and transcription factors.J Biochem. 2012;151(3):247-254.
[42] EL-SEOUDI A, ABD EL KADER T, NISHIDA T, et al. Catabolic effects of FGF-1 on chondrocytes and its possible role in osteoarthritis.J Cell Commun Signal. 2017;11(3):255-263.
[43] CHEN T, CHEN Y, SUN H, et al. Fibroblast growth factors: Potential novel targets for regenerative therapy of osteoarthritis. Chin J Physiol. 2019;62(1):2-10.
[44] GIGOUT A, GUEHRING H, FROEMEL D, et al. Sprifermin (rhFGF18) enables proliferation of chondrocytes producing a hyaline cartilage matrix. Osteoarthritis Cartilage. 2017;25(11):1858-1867.
[45] MORI Y, SAITO T, CHANG SH, et al. Identification of Fibroblast Growth Factor-18 as a Molecule to Protect Adult Articular Cartilage by Gene Expression Profiling.J Biol Chem. 2014;289(14):10192-10200.
[46] LONG F, ORNITZ DM. Development of the Endochondral Skeleton. Cold Spring Harb Perspect Biol. 2013;5(1):a008334.
[47] ZHAO Q, EBERSPAECHER H, LEFEBVRE V, et al.Parallel expression of Sox9 and Col2a1 in cells undergoing chondrogenesis. Dev Dyn. 1997;209(4):377-386.
[48] LEFEBVRE V, DVIR-GINZBERG M. SOX9 and the many facets of its regulation in the chondrocyte lineage. Connect Tissue Res. 2017;58(1): 2-14.
[49] AKIYAMA H, CHABOISSIER MC, MARTIN JF, et al. The transcription factor Sox9 has essential roles in successive steps of the chondrocyte differentiation pathway and is required for expression of Sox5 and Sox6. Genes Dev. 2002;16(21):2813-2828.
[50] DY P, WANG W, BHATTARAM P, et al. Sox9 Directs Hypertrophic Maturation and Blocks Osteoblast Differentiation of Growth Plate Chondrocytes. Dev Cell. 2012;22(3):597-609.
[51] KAPOOR M, MARTEL-PELLETIER J, LAJEUNESSE D, et al. Role of proinflammatory cytokines in the pathophysiology of osteoarthritis. Nat Rev Rheumatol. 2011;7(1):33-42.
[52] XIAO Y, LI B, LIU J, et al. Carvacrol ameliorates inflammatory response in interleukin 1beta-stimulated human chondrocytes.Mol Med Rep. 2018;17(3):3987-3992.
[53] MULLER-LADNER U, ROBERTS CR, FRANKLIN BN, et al. Human IL-1Ra gene transfer into human synovial fibroblasts is chondroprotective. J Immunol. 1997;158(7):3492-3498.
[54] LI MH, XIAO R, LI JB, et al. Regenerative approaches for cartilage repair in the treatment of osteoarthritis.Osteoarthritis Cartilage. 2017; 25(10):1577-1587.
[55] HUH YH, LEE G, LEE KB, et al. HIF-2alpha-induced chemokines stimulate motility of fibroblast-like synoviocytes and chondrocytes into the cartilage-pannus interface in experimental rheumatoid arthritis mouse models. Arthritis Res Ther. 2015;17:302.
[56] CASE JM, SCOPP JM. Treatment of Articular Cartilage Defects of the Knee With Microfracture and Enhanced Microfracture Techniques. Sports Med Arthrosc Rev. 2016;24(2):63-68.
[57] HARRELL CR, MARKOVIC BS, FELLABAUM C, et al. Mesenchymal stem cell-based therapy of osteoarthritis: Current knowledge and future perspectives.Biomed Pharmacother. 2019;109:2318-2326.
[58] CHOI H, LEE RH, BAZHANOV N, et al. Anti-inflammatory protein TSG-6 secreted by activated MSCs attenuates zymosan-induced mouse peritonitis by decreasing TLR2/NF-kappaB signaling in resident macrophages. BLOOD. 2011;118(2):330-338.
[59] AMES RS, LU Q. Viral-mediated gene delivery for cell-based assays in drug discovery. Expert Opinion on Drug Discovery, 2009,4(3):243-256.
[60] BELLAVIA D, VERONESI F, CARINA V, et al.Gene therapy for chondral and osteochondral regeneration: is the future now?. Cell Mol Life Sci. 2018;75(4):649-667.
[61] STEINERT AF, WEISSENBERGER M, KUNZ M, et al. Indian hedgehog gene transfer is a chondrogenic inducer of human mesenchymal stem cells. Arthritis Res Ther. 2012;14(4):R168.
[62] SIEKER JT, KUNZ M, WEIßENBERGER M, et al. Direct bone morphogenetic protein 2 and Indian hedgehog gene transfer for articular cartilage repair using bone marrow coagulates. 2015;23(3): 433-442.
[63] TAO K, FRISCH J, REY-RICO A, et al. Co-overexpression of TGF-β and SOX9 via rAAV gene transfer modulates the metabolic and chondrogenic activities of human bone marrow-derived mesenchymal stem cells. Stem Cell Res Ther. 2016;7:20.
[64] IM EJ, BAIS AJ, YANG W, et al. Recombination–deletion between homologous cassettes in retrovirus is suppressed via a strategy of degenerate codon substitution.Mol Ther Methods Clin Dev. 2014;1: 14022.
[65] YI Y, NOH MJ, LEE KH. Current advances in retroviral gene therapy. Curr Gene Ther. 2011;11(3):218-228.
[66] YAO Y, ZHANG F, PANG PX, et al. In vitro study of chondrocyte redifferentiation with lentiviral vector-mediated transgenic TGF-β3 and shRNA suppressing type I collagen in three-dimensional culture.J Tissue Eng Regen Med. 2011;5(8):e219-27.
[67] MAUER J, MAYO JM, DENFORD K. Comparative ecophysiology of the chromosome races in Viola adunca J.E. Smith. Oecologia. 1978; 35(1):91-104.
[68] BOUGIOUKLI S, SUGIYAMA O, ALLURI RK, et al. In vitro evaluation of a lentiviral two-step transcriptional amplification system using GAL4FF transactivator for gene therapy applications in bone repair. Gene Ther. 2018;25(4):260-268.
[69] WEGMAN F, ÖNER FC, DHERT WJA, et al. Non-viral gene therapy for bone tissue engineering. Biotechnol Genet Eng Rev. 2013;29:206-220.
[70] YANG W, WANG F, FENG L, et al. Applications and Prospects of Non-viral Vectors in Bone Regeneration. Curr Gene Ther. 2018;18(1): 21-28.
[71] PAYNE KA, LEE HH, HALEEM AM, et al. Single intra-articular injection of adeno-associated virus results in stable and controllable in vivo transgene expression in normal rat knees.Osteoarthritis Cartilage. 2011;19(8):1058-1065.
[72] OZEKI N, MUNETA T, KOGA H, et al. Not single but periodic injections of synovial mesenchymal stem cells maintain viable cells in knees and inhibit osteoarthritis progression in rats.Osteoarthritis Cartilage. 2016; 24(6):1061-1070.
[73] EVANS CH, ROBBINS PD, GHIVIZZANI SC, et al. Gene transfer to human joints: progress toward a gene therapy of arthritis. Proc Natl Acad Sci U S A.2005;102(24):8698-8703.
[74] LENG P, DING C, ZHANG H, et al. Reconstruct large osteochondral defects of the knee with hIGF-1 gene enhanced Mosaicplasty. Knee. 2012;19(6):804-811.
[75] HA C, CHO JJ, ELMALLAH RK, et al. A Multicenter, Single-Blind, Phase IIa Clinical Trial to Evaluate the Efficacy and Safety of a Cell-Mediated Gene Therapy in Degenerative Knee Arthritis Patients. Hum Gene Ther Clin Dev. 2015;26(2):125-130.
[76] MALEMUD C. MicroRNAs and Osteoarthritis. Cells.2018;7(8):92.
[77] WU C, TIAN B, QU X, et al. MicroRNAs play a role in chondrogenesis and osteoarthritis (review).Int J Mol Med. 2014;34(1):13-23.
[78] TUDDENHAM L, WHEELER G, NTOUNIA-FOUSARA S, et al. The cartilage specific microRNA-140 targets histone deacetylase 4 in mouse cells. FEBS Lett. 2006;580(17):4214-4217.
[79] MARTINEZ-SANCHEZ A, DUDEK KA, MURPHY CL. Regulation of Human Chondrocyte Function through Direct Inhibition of Cartilage Master Regulator SOX9 by MicroRNA-145 (miRNA-145).J Biol Chem. 2012;287(2):916-924.
[80] LIN EA, KONG L, BAI XH, et al. miR-199a*, a Bone Morphogenic Protein 2-responsive MicroRNA, Regulates Chondrogenesis via Direct Targeting to Smad1. J Biol Chem. 2009;284(17):11326-11335.
[81] JIANG S, LU J, DENG Z, et al. Long noncoding RNAs in osteoarthritis. Joint Bone Spine. 2017;84(5):553-556.
[82] YE D, JIAN W, FENG J, et al. Role of long noncoding RNA ZFAS1 in proliferation, apoptosis and migration of chondrocytes in osteoarthritis. Biomed Pharmacother. 2018;104:825-831.
[83] ATASOY-ZEYBEK A, KOSE GT. Gene Therapy Strategies in Bone Tissue Engineering and Current Clinical Applications. Adv Exp Med Biol. 2018;1119:85-101.
[84] D'MELLO S, ATLURI K, GEARY SM, et al. Bone Regeneration Using Gene-Activated Matrices.AAPS J. 2017;19(1):43-53.
|